[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-221026096--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-221026096","PRESSRELEASE"," TFS HealthScience Unveils New Global Brand Identity","2026-10-22T14:06:26.000+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> New identity makes clear how Swedish-founded CRO works with biotech, pharma and medtech sponsors: radical honesty, scientific urgency, therapeutic depth and teams that stay\u003C\u002Fp>\u003Cp> LUND, Sweden, Oct. 22, 2026 \u002FPRNewswire\u002F -- TFS HealthScience, a global clinical research organization (CRO) headquartered in Lund, Sweden, has launched a new brand identity and claim: Securing the path from science to life. Introduced on October 5, 2026, the identity sets out how TFS works with biotech, pharma and medtech sponsors in more than 40 countries: radical honesty, scientific urgency, therapeutic depth and teams that stay. The people, the leadership and the commitment to sponsor programs stay the same.\u003C\u002Fp>\u003Cp> \"Our new brand shows exactly who we are and where we are going,\" said Markus Granlund, Chief Executive Officer of TFS HealthScience. \"We secure the path from science to life and we do that with a great team that goes above and beyond to make it happen.\"\u003C\u002Fp>\u003Cp> Watch the TFS brand film\u003C\u002Fp>\u003Cp> Watch the brand film at tfscro.com\u002Fnew-brand \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fedge.prnewswire.com\u002Fc\u002Flink\u002F?t=0&l=en&o=4803176-1&h=3674575213&u=https%3A%2F%2Ftfscro.com%2Fnew-brand%2F&a=Watch+the+brand+film+at+tfscro.com%2Fnew-brand+%E2%86%92\">→\u003C\u002Fa>\u003C\u002Fp>\u003Cp> The short film shows the new TFS in practice: how its teams work alongside sponsors from first patient to database lock.\u003C\u002Fp>\u003Cp> What the new brand stands for\u003C\u002Fp>\u003Cp> The identity anchors every study in the company's purpose: to apply a human lens to clinical development so that promising science reaches the patients who need it. TFS began in Lund with a clear idea of how clinical research should be done. Tell sponsors exactly what the data says, act with urgency and keep the same experts on a study from first patient to database lock.\u003C\u002Fp>\u003Cp> The new brand turns that idea into four commitments sponsors can hold TFS to:\u003C\u002Fp>\u003Cp> - Radical honesty. TFS teams tell sponsors exactly what the data says and flag what matters early.\u003C\u002Fp>\u003Cp> - Scientific urgency. Therapeutic leads hold direct decision-making authority, so sponsors get fast decisions without escalation chains.\u003C\u002Fp>\u003Cp> - Therapeutic depth. TFS focuses on five therapeutic areas: dermatology, internal medicine, neuroscience, oncology and ophthalmology. Clinical leads know the indication before kickoff.\u003C\u002Fp>\u003Cp> - Teams that stay. 88% of TFS teams stay for the whole study, 8 percentage points above the industry average. The people who start a trial are still there at database lock.\u003C\u002Fp>\u003Cp> Sponsors work with TFS through full delivery, embedded resourcing or a blend of both, shaped around what they keep in-house and what they hand over.\u003C\u002Fp>\u003Cp> About TFS HealthScience\u003C\u002Fp>\u003Cp> TFS HealthScience is a global clinical research organization (CRO) that partners with biotech, pharma and medtech sponsors to secure the path from science to life. Founded in Lund, Sweden, in 1996, TFS operates in more than 40 countries. The company focuses on five therapeutic areas: dermatology, internal medicine, neuroscience, oncology and ophthalmology. Learn more at \u003Ca target=\"_blank\" href=\"https:\u002F\u002Fedge.prnewswire.com\u002Fc\u002Flink\u002F?t=0&l=en&o=4803176-1&h=1597274035&u=https%3A%2F%2Ftfscro.com%2F&a=tfscro.com\">tfscro.com.\u003C\u002Fa>\u003C\u002Fp>\u003Cp> View original content to download multimedia:https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Ftfs-healthscience-unveils-new-global-brand-identity-302915828.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","New identity makes clear how Swedish-founded CRO works with biotech, pharma and medtech sponsors: radical honesty, scientific urgency, therapeutic depth and tea",[16,21,26,31,36,37,42,47,52,57],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-221026115"," ZwitterCo Announces Strategic Investment from Ecolab to Drive Water Circularity","2026-10-22T15:21:24.000+02:00","Investment enables companies to collaborate on advanced water reuse and circularity solutions for food and beverage manufacturers. WOBURN, Mass., Oct. 22, 2026 ",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-221026113"," ELEGOO Brings Professional-Grade 3D Scanning to a Wider Range of Creators with the Upcoming M1 Ultra","2026-10-22T15:17:24.000+02:00","SHENZHEN, China, Oct. 22, 2026 \u002FPRNewswire\u002F -- ELEGOO, a rapidly developing brand in global smart manufacturing, is expanding its 3D creation ecosystem with the",{"id":27,"title":28,"pubDate":29,"logoUrl":8,"thirdParty":11,"orgId":13,"description":30},"CSN-221026109"," Raytron Industrial Launches TN660 and TN463 Thermal Cameras for Dynamic Testing and Continuous Condition Monitoring","2026-10-22T15:05:25.000+02:00","YANTAI, China, Oct. 22, 2026 \u002FPRNewswire\u002F -- Raytron Industrial today announced the launch of two new products: the TN660 High Frame Rate Fixed-Mount Thermal Ca",{"id":32,"title":33,"pubDate":34,"logoUrl":8,"thirdParty":11,"orgId":13,"description":35},"CSN-221026108"," 77% of Enterprises Have Paid a Price for Ungoverned AI Agents","2026-10-22T15:02:24.000+02:00","New research from Redwood Software finds agentic AI is scaling faster than the integration, ownership and governance necessary to run it with confidence. VIENNA",{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":11,"orgId":13,"description":14},{"id":38,"title":39,"pubDate":40,"logoUrl":8,"thirdParty":11,"orgId":13,"description":41},"CSN-221026094"," Qblox Advances Hybrid Quantum Computing with Integration of NVIDIA DGX Spark leveraging NVIDIA NVQLink","2026-10-22T14:02:25.000+02:00","The Qblox Cluster has been integrated with multiple NVIDIA GPUs, enabling real-time control for hybrid quantum-classical computing with roundtrip latency below ",{"id":43,"title":44,"pubDate":45,"logoUrl":8,"thirdParty":11,"orgId":13,"description":46},"CSN-221026093"," Paradigm Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Trial for SD-101 (Zorblesia™) in Epidermolysis Bullosa","2026-10-22T14:01:25.000+02:00","SD-101 (Zorblesia™) is the First Topical Therapy Being Developed to Treat Wounds and Lesions Across the Entire Skin Surface in Patients with Three Major Subtype",{"id":48,"title":49,"pubDate":50,"logoUrl":8,"thirdParty":11,"orgId":13,"description":51},"CSN-221026082"," Context Labs joins Carbon Measures, as one of the coalition's first technology members","2026-10-22T13:01:24.000+02:00","Context Labs to support Carbon Measures' effort to make product-level carbon datareliable for procurement, lending, and regulatory decisions CAMBRIDGE, Mass., O",{"id":53,"title":54,"pubDate":55,"logoUrl":8,"thirdParty":11,"orgId":13,"description":56},"CSN-221026060"," GAC Launches AION UT and AION V in Italy","2026-10-22T11:17:24.000+02:00","MILAN, Oct. 22, 2026 \u002FPRNewswire\u002F -- GAC launched the AION UT and AION V in Italy on October 8th, holding a media presentation and test-drive event at Superstud",{"id":58,"title":59,"pubDate":60,"logoUrl":8,"thirdParty":11,"orgId":13,"description":61},"CSN-221026056"," The Radiance of All Things: A Retrospective of Chu Teh-Chun opens at the Art Museum of China Academy of Art","2026-10-22T11:11:24.000+02:00","HANGZHOU, China, Oct. 22, 2026 \u002FPRNewswire\u002F -- In 2028, the China Academy of Art will celebrate its centenary. On October 19, 2026, one of the Academy's major c"]